3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
42
Lymphoma, Large B-Cell, Diffuse
34
Burkitt Lymphoma
32
Lymphoma
25
Lymphoma, Follicular
17
Rhabdomyosarcoma
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, B-Cell
11
Neuroblastoma
10
Lymphoma, Non-Hodgkin
10
Leukemia
10
Sarcoma, Ewing
9
Medulloblastoma
9
Leukemia, Biphenotypic, Acute
9
Recurrence
8
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Lymphoma, T-Cell, Peripheral
8
Lymphoma, Mantle-Cell
7
Lymphoma, B-Cell, Marginal Zone
7
Hodgkin Disease
7
Wilms Tumor
5
Sarcoma
5
Retinoblastoma
5
Osteosarcoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Ganglioneuroblastoma
4
Down Syndrome
4
Interventions
Cyclophosphamide
8
ibrutinib
5
fludarabine phosphate
5
fludarabine
5
pirtobrutinib
4
Mesna
4
obinutuzumab
3
acalabrutinib
3
Mycophenolic Acid
3
Melphalan
3
venetoclax
2
Whole-Body Irradiation
2
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Busulfan
2
Bone Marrow Transplantation
2
ARQ531
2
ricolinostat
1
idelalisib
1
idecabtagene vicleucel
1
Vincristine
1
Stem Cell Transplantation
1
Rabeprazole
1
Prednisone
1
Leukapheresis
1
Itraconazole
1
Filgrastim
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, B-Cell
×
Vincristine
×
1 year
×
Clear all
NCT06564038
2026-05-14
Soundtrack-E
AstraZeneca
Phase 1/2
Recruiting
408 enrolled